Full Judgment Text
* IN THE HIGH COURT OF DELHI AT NEW DELHI
Judgment reserved on: 28.07.2022,
30.08.2022 & 24.08.2022
Date of decision: 06.09.2022
+ BAIL APPLN. 2202/2022 & CRL.M.(BAIL) 885/2022
DR. L. PRAVEEN KUMAR ..... Petitioner
Through: Mr. Rajiv Nayar and Mr. Trideep Pais,
Senior Advocates with Mr. Mahesh
Agarwal, Mr. Rishi Agarwala, Mr.
Avishkar Singhvi, Mr. Shubham, Mr.
Vishnu T. Mr. Parminder Singh, Mr.
Ashish Hira, Mr. Sandeep & Mr.
Kumar Satyam Agarwal, Advocates.
Versus
CENTRAL BUREAU OF INVESTIGATION ..... Respondent
Through: Mr. Anupam S Sharrma, SPP for CBI
with Mr. Anurag K Andley, Mr.
Prakarsh Airan & Ms. Harpreet Kalsi,
Advocates.
Inspector Pushpender Parashar, CBI,
ACB, New Delhi.
+ BAIL APPLN. 2290/2022 & & CRL.M.(BAIL) 915/2022
DINESH DUA ..... Petitioner
Through: Mr. Siddharth Aggarwal, Sr. Adv.,
Mr. Davesh Bhatia, Mr. Rajat Mathur,
Mr. Raghvendra N. Budholia, Mr.
Vishwajeet, Ms. Priya Pachouri, Mr.
Udbhav, Advs., Mr. Arun Khatri, Mr.
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 1 of 35
Akshay, Mr. Sahil Khurana, Ms.
Shalini Halder, Mr. Mohit, Ms.
Saumya, Advocats.
Versus
CENTRAL BUREAU OF INVESTIGATION ANTI CORRUPTION
BRANCH
..... Respondent
Through: Mr. Anupam S Sharrma, SPP-CBI
with Mr. Prakarsh Airan, Mr.
Sidhanth Mor, Ms. Harpreet Kalsi,
Advocates.
AND
+ BAIL APPLN. 2262/2022
S. ESWARA REDDY ..... Petitioner
Through: Mr. Mohit Mathur, Sr. Advocate with
Sh. Arun Khatri, Mr. Akshay, Mr.
Sahil Khurana, Mr. Mohit, Ms. Shalini
and Ms. Saumya, Advocates.
Versus
CENTRAL BUREAU OF INVESTIGATION ..... Respondent
Through: Mr.Anupam S. Sharrma, SPP with
Ms. Harpreet Kalsi and Mr. Prakarsh
Airan, Advocates.
CORAM:
HON'BLE MS. JUSTICE ANU MALHOTRA
JUDGMENT
ANU MALHOTRA, J
1. The applications filed by Dr. L. Praveen Kumar, Dinesh Dua
and S. Eswara Reddy i.e. BAIL APPLN. 2202/2022, BAIL APPLN.
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 2 of 35
2290/2022 & BAIL APPLN. 2262/2022 respectively are taken up
together, in as much as, all the three applicants seek the grant of bail in
relation to FIR No. RC0032022A0037 dated 19.06.2022 filed by the
CBI/(ACB) Delhi under Sections 120B/420/468/471 of the Indian
Penal Code, 1860 and Sections 7/7A/8 of the PC Act, 1988. The
applicants, through their respective applications submit that they have
been falsely implicated in the case.
2. The status report of the CBI in BAIL APPLN. 2202/2022 dated
26.07.2022 and status reports of the CBI in BAIL APPLN. 2290/2022
and BAIL APPLN. 2262/2022 dated 06.08.2022 are premised on the
same facts.
3. The version put forth by the CBI is to the effect that the FIR/RC
bearing case no. RC0032022A0037, CBI, ACB, Delhi was registered
by Respondent/CBI on 19.06.2022 on the basis of source information
against:
(1) Sh. S. Eswara Reddy, Joint Drug Controller (JDC), India at Head
Quarter, CDSCO, New Delhi (applicant of BAIL APPLN.
2262/2022),
(2) Ms. Guljit Sethi @ Guljit Chaudhri, Director M/s Bioinnovat
Research Services Private Limited, Delhi;
(3) Sh. Dinesh Dua, Director, M/s Synergy Network India Private
Limited, Delhi (applicant of BAIL APPLN. 2290/2022);
(4) Sh. L. Praveen Kumar, Associate Vice President and Head-
National Regulatory Affairs (NRA), M/s Biocon Biologics Limited,
Bangalore (applicant of BAIL APPLN. 2202/2022);
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 3 of 35
(5) Sh. Animesh Kumar, Assistant Drug Inspector (ADI), CDSCO,
New Delhi and other unknown officials of CDSCO, New Delhi for the
alleged commission of offences punishable under Sections 7, 7A, 8 of
PC Act, 1988 and under Sections 120-B, 420, 468 and 471 of Indian
Penal Code, 1860.
4. It is submitted by the CBI through the status report dated
26.07.2022 that it had been alleged in the FIR that the accused Dr. S
Eswara Reddy, Joint Drug Controller, India, Head Quarter, Central
Drugs Standard Control Organisation (CDSCO), New Delhi (applicant
of BAIL APPLN. 2262/2022) was dealing with the processing of files
related to applications for approval of drugs and vaccines by various
pharma companies and in relation thereto, he received three files of
M/s Biocon Biologics Limited, Bangalore including one file related to
waiver of Phase-III, Clinical trial of “Insulin Aspart Injection” for
processing and approval and that a bribe amount of Rs. 30,000/- was
paid by the accused Guljit Sethi to Animesh Kumar, Assistant Drug
Inspector (ADI) for processing the file.
5. It is stated through the status report that the accused S. Eswara
Reddy (applicant of BAIL APPLN. 2262/2022) in alleged criminal
conspiracy with co-accused persons and other unknown officers of
CDSCO, had manipulated minutes of meeting of Subject Expert
Committee dated 18.05.2022 and further included the aforesaid third
file of M/s Biocon Biologics Limited, Bangalore in SEC meeting on
15.06.2022 which resulted in wrongful gain to M/s Biocon Biologics
Limited, Bangalore. It was also submitted through the said status
report that the investigation conducted till then revealed that Guljit
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 4 of 35
Sethi was acting as a conduit on behalf of pharmaceutical companies
including above-mentioned Pharma companies and had delivered/
arranged huge bribe amounts for senior officers of CDSCO on
different occasions for processing their respective files favorably and
that the source revealed that Dr. L. Praveen Kumar (applicant of BAIL
APPLN. 2202/2022) Associate Vice President and Head-National
Regulatory Affairs (NRA), M/s Biocon Biologics Limited, Bangalore
had agreed to pay an undue pecuniary advantage of Rs 9,00,000/-
(Rupees Nine Lacs) as motive/reward to Dr. S. Eswara Reddy, Joint
Drug Controller, CDSCO, New Delhi (applicant of BAIL APPLN.
2262/2022) for processing his file favorably and that the source further
revealed that Guljit Sethi directed Dinesh Dua (applicant of BAIL
APPLN. 2290/2022) to pay a part of the agreed amount to Dr. S.
Eswara Reddy at his residence on 20.06.2022.
6. It is stated further through the status report that on the basis of
the said information, a trap was laid on 20.06.2022 and during the trap
proceedings, Dr. S. Eswara Reddy and Dinesh Dua were caught red-
handed with a bribe amount of Rs.4,00,000/- (Rupees Four Lacs),
whereafter, searches were conducted at the residential premises of Dr.
S. Eswara Reddy at D-II, 235, Vinay Marg, Chanakya Puri, New
Delhi, of Dinesh Dua at A-103, Narang Colony, Janak Puri, New
Delhi, of Guljit Sethi at A-1/17, Safdarjung Enclave, New Delhi, of
Animesh Kumar at J-803, Skytech Mattrot, Sector – 76, Noida, Flat
No. 202, Brindeshwar Enclave, Road no. 5, Indira Puri, Patna and of
Dr. L. Praveen Kumar at C-403, Hinduja Lake, Front Estate, Cave
Temple Road, Hulimavu, Bengaluru.
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 5 of 35
7. It is stated through the status report further that searches were
also conducted at the office premises of the aforesaid accused persons
and various incriminating articles and documents related to the case
were seized from the residential and office premises of the accused
persons and that consequent to the trap proceedings, Dr. S. Eswara
Reddy, Joint Drug Controller (India), CDSCO, Head Quarter, New
Delhi, Dinesh Dua, Director, M/s Synergy Network India Private
Limited, Delhi, Guljit Sethi @ Guljit Choudhri, Director of M/s
Bioinnovat Research Services Private Limited, Delhi were arrested on
20.06.2022 whilst Animesh Kumar, Assistant Drug Inspector (ADI),
CDSCO, New Delhi was arrested on 21.06.2022 and Dr. L. Praveen
Kumar was arrested on 20.06.2022 at Bengaluru and was produced
before the concerned competent Court of ACMM at Bengaluru on
21.06.2022, whereby, transit remand was granted from Bengaluru to
Delhi and he was produced before the Vacation Judge, CBI-19 (PC
Act), Rouse Avenue Courts, New Delhi on 22.06.2022.
8. The CBI has alleged to the effect that credible information had
been received that Dr. L. Praveen Kumar had conspired with other co-
accused Guljit Sethi to pay Rs. 09 Lacs to the CDSCO officials for
getting favour in matters of Biocon Biologicals Limited pertaining to
03 files including one file related to waiver of phase-III clinical trial of
„Insulin Aspart‟ injection pending in CDSCO and in furtherance of
this conspiracy, Rs. 04 Lacs was delivered to the accused Shri S.
Eswara Reddy on 20.06.2022.
9. Inter alia, the CBI submitted that Dr. L. Praveen Kumar was
holding a very senior position in M/s Biocon Biologics Limited, with
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 6 of 35
an authority within his office. The CBI further submitted that there
was sufficient evidence that Dr. L. Praveen Kumar had committed the
offence in pursuance of a criminal conspiracy and that in a case of
conspiracy, the evidence against a particular accused has to be read
against the co-accused as well and that the evidence of recovery
during the proceedings in Delhi from the co-accused which is also an
evidence against Dr. L. Praveen Kumar and there are other evidences
including the telephonic conversation of Dr. L. Praveen Kumar with
the co-accused which clearly established his involvement in the
commission of the offence and also that the bribe amount was being
paid in connivance with him and with his consent.
10. It is further submitted by the CBI that in the “Whatsapp” chat
with the co-accused, Dr. L. Praveen Kumar had suggested that the
word “ data ” be changed to “ protocol ” as was subsequently done in the
Minutes of Meeting of the Subject Expert Committee (SEC) held on
18.05.2022 and that there were other corroborative evidence against
Dr. L. Praveen Kumar.
11. Inter alia, the CBI has submitted that the matter has huge
implications qua the health standards of the country which are being
compromised by the accused persons by indulging in a conspiracy
with each other and the applicants are involved in a serious economic
offence with serious implications over the health standard and the
economy of the country. Inter alia, the CBI submitted that the offence
was committed with a cool calculation and deliberate design with an
eye on personal profit regardless of the consequences to the
community and that the present case constitutes a class apart and
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 7 of 35
needs to be visited with a different approach in the matter of bail in
view of the serious economic and health implications in the matter
pursuant to a deep-rooted conspiracy which has necessarily to be
viewed seriously.
12. The CBI has submitted that M/s Biocon Biologics Limited was
the ultimate beneficiary of the favorable recommendation and Dr. L.
Praveen Kumar was taking care of the application and approval
process from the CDSCO and that he was the prime conspirator in the
huge money transaction which took place on his behalf.
13. The status report dated 06.08.2022 that has been submitted
under the signatures of the Inspector of Police, CBI, ACB, New Delhi
in BAIL APPLN. 2290/2022 qua the applicant named Dinesh Dua
apart from reiterating the submissions made in the status reports in
BAIL APPLN. 2202/2022 and BAIL APPLN. 2262/2022, it has been
submitted by the CBI that in pursuance of the conspiracy between Dr.
L. Praveen Kumar, Guljit Sethi to pay Rs. 9 Lakhs to CDSCO officials
for getting favors with M/s Biocon Biologics Limited, Bangalore
pertaining to 03 files including one file related to waiver of phase-III
clinical trial of „Insulin Aspart‟ injection pending in CDSCO, Rs. 04
Lacs was delivered by the applicant- Dinesh Dua (applicant of BAIL
APPLN. 2290/2022) to the accused Shri S. Eswara Reddy on
20.06.2022 and that Dinesh Dua, the accused was caught red handed
and was arrested and that apart from the recovery of the bribe amount
during the trap proceedings in Delhi from the co-accused, there was
other evidence including telephonic conversation of Dinesh Dua with
the co-accused which clearly established his involvement in the
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 8 of 35
commission of the offence and that the investigation had revealed that
in telephonic conversation with the co-accused, Dinesh Dua had
agreed to deliver the bribe amount with the public servant in view of a
favour extended by him to M/s Biocon Biologics Limited, Bangalore
and that the role of Dinesh Dua could not be ignored, in as much as,
he had played a very important role in the delivery of the bribe amount
on behalf of other accused so that M/s Biocon Biologics Limited,
Bangalore gets a favorable recommendation from the CDSCO and that
Dinesh Dua was the prime conspirator in a huge money transaction
where he delivered the bribe money to the accused.
14. During the pendency of the present applications, the charge
sheet dated 18.08.2022 has since been filed by the CBI, copy of which
has been placed on the record by the CBI which indicates that it has
been filed against Sh. S. Eswara Reddy, Joint Drug Controller (JDC),
India at Head Quarter, CDSCO, New Delhi (applicant of BAIL
APPLN. 2262/2022) (A-1), Ms. Guljit Sethi @ Guljit Chaudhri,
Director, M/s Bioinnovat Research Services Private Limited, Delhi
(A-2); Sh. Dinesh Dua, Director, M/s Synergy Network India Private
Limited, Delhi (applicant of BAIL APPLN. 2290/2022) (A-3); Sh. L.
Praveen Kumar, Associate Vice President and Head-National
Regulatory Affairs (NRA), M/s Biocon Biologics Limited, Bangalore
(applicant of BAIL APPLN. 2202/2022) (A-4); Sh. Animesh Kumar,
Assistant Drug Inspector (ADI), CDSCO, New Delhi (A-5).
15. As per the investigation conducted by the CBI, the CBI as put
forth through the charge sheet, it has been submitted that the
investigation revealed that Sh. S. Eswara Reddy (Al) (applicant of
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 9 of 35
BAIL APPLN. 2262/2022) who was posted as Joint Drug Controller
in Biological Division of the office of the Drug Controller General of
India (DCGI), Central Drug Standard Control Organisation (CDSCO)
(HQ), FDA Bhawan, New Delhi since 2014 and was the head of the
Biological Division; that Sh. Animesh Kumar (A2) was working as an
Assistant Drug Inspector in Biological Division of CDSCO (HQ)
since February 2017; that Sh. Dinesh Dua (A3) (applicant of BAIL
APPLN. 2290/2022) was a Marketing Consultant in Synergy
Networks Pvt. Ltd and was known to Sh. S. Eswara Reddy and Ms.
Guljit Sethi; Ms. Guljit Sethi @ Guljit Chaudhri (A4), Managing
Director, M/s Bioinnovat Research Service Pvt. Ltd. who was a
consultant for various pharmaceutical companies and looked after the
regulatory affairs of all such companies and charged retainer fee as
well as project fee also for the same. Inter alia, it was stated through
the charge sheet that she also pursued the regulatory matters of M/s
BBL as consultant and that Sh. L. Praveen Kumar @ Praveen Kumar
Lakshminarayana (A5) was the Associate Vice President in M/s
Biocon Biologics Ltd. (hereinafter called as M/s BBL) since
17.01.2022 and was the Head of National Regulatory Affairs of M/s
BBL.
16. It has been stated further through the charge sheet that
investigation revealed that an application dated 10.01.2022 was
received in the office of the DCGI, Delhi from M/s BBL vide which
the said company had requested for pre-submission meeting prior to
submission of an application in form CT-18 for the grant of
permission to import Insulin Aspart Bulk and its formulations (vials,
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 10 of 35
pre-filled pens and cartridges) and that the company had requested the
DCGI to provide guidance to proceed with the application for
permission to import and market Insulin Aspart Bulk and its
formulations with waiver of local clinical trial and that the company
had specifically mentioned the waiver of phase-III clinical trial in its
application. The said application is stated to have been reviewed by
Sh. Chinmay Patel, Drug Inspector and after taking replies from M/s
BBL regarding certain queries, the proposal of M/s BBL was taken up
during the SEC (Subject Expert Committee) meeting dated 17.03.2022
wherein it was recommended that the firm i.e. M/s Biocon Biologics
Limited would be required to generate the safety and efficacy data on
the Indian Population alongwith other requirements as per guidelines
on similar Biologics and the said recommendation was communicated
to M/s BBL vide letter dated 05.04.2022.
17. It has further been stated through the charge sheet that the
investigation revealed that on 19.04.2022, M/s BBL submitted 04
applications online in CDSCO SUGAM portal with the following
application numbers in respect of drug namely 'Insulin Aspart':-
1. BIO/CT18/FF/2022/31689-Vial.
2. BIO/CT18/FF/2022/31691-Pre-filled pens.
3. BIO/CT18/FF/2022/29555-Bulk.
4. BIO/CT18/FF/2022/31694-Cartridges.
and that vide all the aforesaid applications, M/s BBL had requested the
CDSCO for granting the permission to import and market the drug
namely Insulin Aspart and the company had also requested for waiver
of local clinical trial on the basis of already generated clinical data.
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 11 of 35
18. It is stated through the charge sheet that the investigation
revealed that on 19.04.2022, the details of the aforesaid applications
were shared by Shri L Praveen Kumar (A5) with Ms. Guljit Sethi (A4)
in a whatsapp chat and that the investigation revealed that the
aforesaid applications were marked by Shri Jayant Gangakhedkar,
Assistant Drug Controller (ADC), the Nodal Officer to the reviewing
officers namely Shri Chinmay Patel, DI; Sh. Animesh Kumar (A2),
ADI and Shri Navin Yadav, DI (02 applications-Bulk and Cartridges)
respectively on 20.04.2022.
19. It is stated further through the charge sheet that the investigation
revealed that on 13.05.2022, Ms. Guljit (A4) shared the invitation
letter dated 13.05.2022 (Proposal of M/s BBL was not included in
this), sent by CDSCO to the experts regarding the SEC meeting
scheduled to take place on 18.05.2022, with Shri L Praveen Kumar
(A5) on whatsapp after which the following chat is stated to have
taken place between Ms. Guljit (A4) and Dr. L. Praveen Kumar (A5)
(applicant of BAIL APPLN. 2202/2022) of them:
“A-4 Guljit-have to make the invite happen
A-5 L Praveen Kumar- Yeah Guljit. Please discuss with
Dr. Reddy (A1) and get it included.
A-4 Guljit-DI has to process These are older app Will
do
A-5 L Praveen Kumar-Ok Thanks, Guljit .”
20. It is stated further through the charge sheet to the effect that
thereafter, an email dated 16.05.2022 was sent by Ms. Amita Nawani,
M/s BBL to CDSCO requesting therein for inclusion of the
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 12 of 35
applications related to Insulin Aspart in the upcoming SEC dated
18.05.2022.
21. It is stated through the charge sheet further that on receipt of the
said email on 17.05.2022, Shri S. Eswara Reddy (A1) directed Shri
Jayant Gangakhedkar to include the agenda of M/s BBL in the
upcoming SEC i.e. SEC meeting 18.05.2022 and on the same day i.e.
Shri Jayant Gangakhedkar directed Shri Animesh Kumar, ADI (A2) to
put up the proposal for sending the same to the SEC division for
including the agenda of M/s BBL as additional agenda in the SEC
Meeting dated 18.05.2022 and as directed by Shri Jayant
Gangakhedkar, Sh. Animesh Kumar, Assistant Drug Inspector (A2)
put up the said proposal on 17.05.2022 and marked the same to Sh.
Jayant Gangakhedkar, ADC who further marked the proposal to Shri
A.K. Pradhan, Joint Drug Controller, SEC Division, CDSCO and
thereafter the invitation letter dated 17.05.2022 was sent to the experts
mentioning the agenda of M/s BBL.
22. The charge sheet further states that as per investigation
conducted, it was revealed that on 17.05.2022, Ms. Guljit (A4) had
following conversation with Shri L.Praveen Kumar (A5):-
“A-4 Guljit- Am At DCGI working on Insulin Aspart……
You should receive the SEC invite for tomorrow….. Have
prepared Dr Reddy (A1) for the same.”
23. The charge sheet states that investigation further revealed that
thereafter, Shri L Praveen Kumar (A5) shared with Ms. Guljit (A4) an
invitation letter dated 17.05.2022, sent by CDSCO to the experts
regarding the additional agenda of M/s Biocon Biologics Limited in
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 13 of 35
respect of Insulin Aspart for inclusion of same in SEC meeting
scheduled to take place on 18.05.2022 and on 18.05.2022, the
applications of M/s BBL were taken up in SEC meeting and during the
said meeting, Shri S.Eswara Reddy (A1) (applicant of Bail Appl.
No.2262/2022) was present online through Webex and the draft
recommendations of the meeting pertaining to biological division were
prepared by Shri Animesh Kumar, ADI (A2) and that the said draft
recommendation prepared by Shri Animesh Kumar, ADI (A2) on
18.05.2022, in respect of M/s BBL's applications was stated in the
charge sheet to be to the effect:-
“After detailed deliberation, the committee
recommended for grant of permission to import and
market the drug with waiver of Phase 3 clinical trial
in the country with the condition that firm shall
conduct Phase 4 clinical trial in India (which also
includes a sub-set population to generate PK/PD
and immunogenicity and submit the 'data' to this
office before placing the drug in the market) as per
existing guidelines in the country.”
24. The charge sheet states that as per the investigation conducted,
it was revealed that on 18.05.2022, Dr. L. Praveen Kumar (A5)
(applicant of BAIL APPLN. 2202/2022) on whatsapp requested Ms.
Guljit (A4) to check with Animesh (A2) regarding draft SEC minutes
and to share and the investigation revealed that on 19.05.2022, the
whatsapp chat that took place between Shri L Praveen Kumar (A5)
and Ms. Guljit (A4) is as under:-
| Guljit<br>(A4) | Firm presented proposal for import and marketing<br>the drug with waiver of Phase 3 trial in the country.<br>The firm presented detailed proposal alongwith CMC,<br>pre-clinical and clinical trial data. The committee |
|---|
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 14 of 35
| noted that, firm has conducted Phase 1 and Phase 3<br>trial with the drug in Germany and USA respectively<br>and based on the results of the trial, the drug has been<br>granted marketing authorization by EMA and Health<br>Canada. After detailed deliberation, the committee<br>recommended for grant of permission to Import and<br>market the drug with waiver of Phase 3 clinical trial<br>in the country with a condition that firm shall conduct<br>Phase 4 clinical trial in India (which also includes a<br>sub-set population to generate PK/PD and<br>immunogenicity and submit the data to this office<br>before placing the drug in market) as per existing<br>guidelines in the country.<br>Highly confidential<br>Even the time was set up at 310 pm | |
|---|---|
| L<br>Praveen<br>Kumar<br>(A5) | Thanks Guljit<br>"and submit the data to this office before placing the<br>drug in market"<br>means cannot launch the product until Phase IV trial<br>is completed & data submitted to CDSCO?<br>Which is like Phase III trial, we should try to see<br>whether It can get modified as follows:<br>.....firm shall conduct Phase 4 clinical trial in India<br>(which also includes a sub-set population to generate<br>PK/PD and Immunogenicity and *get the protocol<br>approved by* this office before placing the drug In<br>market) as per existing guidelines in the country. |
25. The charge sheet states further that the investigation revealed
that on 20.05.2022, Sh. Animesh Kumar, ADI, (A2) got modified the
draft recommendations dated 18.05.2022 and substituted the word
„ data' to 'protocol in the draft recommendations pertaining to M/s
BBL as per directions of Shri S. Eswara Reddy (A1) and thereafter,
draft recommendation pertaining to the aforesaid meeting was finally
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 15 of 35
got approved by SEC members on 23.05.2022, which is stated to be as
follows:
“After detailed deliberation, the committee
recommended for grant of permission to import and
market the drug with waiver of Phase III clinical trial
In the country with the condition that firm should
conduct Phase IV clinical trial in India (which also
includes a sub-set population to generate PK/PD and
immunogenicity and submit the 'protocol' to CDSCO
before placing the drug in the market) as per existing
guidelines in the country.”
26. It is stated through the charge sheet that the investigation
revealed that the draft recommendations dated 18.05.2022 were
modified by substituting the word from 'data' to 'protocol' to favour
the company M/s BBL and that the investigation revealed that the
telephonic conversations dated 18.05.2022, 19.05.2022, 15.06.2022,
19.06.2022 & 20.06.2022 between Ms. Guljit Sethi, Shri L. Praveen
Kumar (A5), Shri Animesh Kumar (A2) and Shri Dinesh Dua (A3)
have established that 50% of undue advantage of Rs. 09 Lakhs was
agreed by L.Praveen Kumar (A5) to be paid to Shri S.Eswara Reddy
(A1) and that the investigation further established that Ms. Guljit (A4)
handed over Rs. 5 Lakhs as undue advantage to Shri Dinesh Dua (A3)
on 20.06.2022 for handing over the same to Shri S.Eswara Reddy (A1)
and on 20.06.2022, a trap team comprising of Sh. Sanjay Malhotra,
(TLO/Inspector) and other CBI staff from the CBI, ACB, Delhi along
with independent witnesses reached near the residence of Shri
S.Eswara Reddy @ Sanapa Reddy (A1) situated at D-II/235, Vinay
Marg, Chanakyapuri, New Delhi at about 6.35 AM and took suitable
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 16 of 35
position and the TLO Shri Sanjay Malhotra was informed by the
source that Sh. Dinesh Dua (A3) would come to the residence of Sh.
Eswara Reddy @ Sanapa Reddy (A1) to handover the bribe amount of
Rs.5 lakhs to Sh. Eswara Reddy @ Sanapa Reddy (Al) as undue
advantage in return of favour done by Sh. Eswara Reddy @ Sanapa
Reddy (A1) in facilitation of the work of the company named M/s
Biocon Biologics Limited.
27. The charge sheet states that the investigation revealed that at
about 09.00 AM, Shri Dinesh Dua (A3) reached at the residence of Sh.
Eswara Reddy @ Sanapa Reddy (A1) in a Toyota Innova car of a
Metallic Grey Colour and on alighting from the same, entered through
the main gate carrying a white coloured bag in his hand into the
residence of Sh. Eswara Reddy @ Sanapa Reddy (A1) and at 9.30
AM, Sh. Dinesh Dua (A3) came out from the main gate of the
residential premises of Sh. Eswara Reddy @ Sanapa Reddy (A1)
without the bag and immediately thereafter, all the team members
rushed towards the main gate of the residence of Sh. Eswara Reddy @
Sanapa Reddy (A1) and intercepted Sh. Dinesh Dua (A3) outside the
main gate. It is stated further through the charge sheet that the
investigation revealed that after disclosing the identity of the CBI
team, Sh. Dinesh Dua (A3) was challenged by the TLO Shri Sanjay
Malhotra that he had given undue advantage of Rs.5 Lakhs to Sh.
Eswara Reddy @ Sanapa Reddy on which he got perplexed and kept
mum and he was enquired about the white coloured bag which he was
carrying while entering into the residence of Sh. Eswara Reddy @
Sanapa Reddy (A1), upon which he admitted to have kept the same,
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 17 of 35
on a chair which was placed in the sit-out of the residence of Sh.
Eswara Reddy @ Sanapa Reddy (Al).
28. The charge sheet states that thereafter the CBI team along with
both independent witnesses Shri V. Vignesh & Shri C Satyamoorthi
and Sh. Dinesh Dua (A3) entered into the residential premises of Sh.
Eswara Reddy @ Sanapa Reddy (Al) who was standing inside the
lawn of his residence, the CBI team apprehended him after disclosing
its identity and the TLO Shri Sanjay Malhotra challenged Shri
S.Eswara Reddy (A1) of having demanded and accepted an undue
advantage of Rs.5 lakhs from Sh. Dinesh Dua (A3) upon which Sh.
Eswara Reddy @ Sanapa Reddy (Al) became perplexed and kept mum
and thereafter, Sh. Dinesh Dua (A3) pointed out towards one chair
made up of bamboo placed in the sit out of the said residence on
which the white coloured bag was kept, which on directions of the
TLO, Sh. V. Vignesh, the independent witness checked and found
within the said white coloured bag, a black coloured cloth bag and a
transparent plastic bag and on the black color cloth bag "KAREN
MILLEN" was written which was opened by independent witness Sh.
V. Vignesh on the directions of the TLO and from the same, eight
bundles of Indian currency notes having denomination of Rs.500/-
which were counted by both the independent witnesses which were
found to be total amounting to Rs. 4,00,000/- (Rs.500X800) and the
said recovered amount of Rs.4 lakhs was kept in the same black
coloured cloth bag from which it was recovered and the said black
coloured cloth bag was signed by the TLO and both the independent
witnesses and thereafter, the said black coloured cloth bag containing
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 18 of 35
Rs.4 Lakhs was kept in a Yellow colour envelope and sealed with the
CBI brass seal and marked as "Trap Money in RC-37(A)/2022".
29. It is further stated through the charge sheet that the
investigation further revealed that when the independent witness
opened the transparent plastic bag on which 'Christina' was written, he
found one painting wrapped in yellow coloured paper, one paper was
found on the backside of the painting on which it was written
'Warlukurlangu Artist of Yuendumu' and the paper found on the
backside of the painting which was signed by the TLO and both the
independent witnesses and it was also sealed in a white cloth parcel
with the CBI brass seal.
30. It is further stated through the charge sheet that the investigation
revealed that on personal search of Sh. Dinesh Dua (A3) by the
independent witness, a bundle of Indian Currencies totalling to Rs.1
lakh, out of which Rs. 98,000/- were in the denomination of Rs.
2,000/- and remaining amount of Rs. 2,000/- were in the denomination
of Rs. 500/-, was recovered from the left side front pocket of Sh.
Dinesh Dua‟s pant. The said bundle of Indian Currency notes
amounting to Rs.1 lakh was kept in a brown coloured envelope, sealed
using the CBI brass seal and marked as “Money recovered from
Dinesh Dua in RC 37(A)/2022.”
31. It has been further stated through the charge sheet that the
investigation established that the accused Shri L. Praveen Kumar
(A3), National Regulatory Head, M/s Biocon Biologics Limited had
the duty to look after all the regulatory issues of his company and for
the regulatory work pertaining to drug namely Insulin Aspart, he had
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 19 of 35
engaged Ms. Guljit Sethi @ Guljit Chaudhri (A4) who was pursuing
the applications filed by M/s BBL in CDSCO and that the
investigation has also established that Shri Animesh Kumar (A2) and
Shri S.Eswara Reddy (Al) were instrumental in putting the agenda
pertaining to M/s BBL in SEC meeting dated 18.05.2022 and during
the SEC meeting also, Shri S.Eswara Reddy (Al) played an important
role in getting favour for the company M/s BBL and that after
completion of the SEC, the draft minutes were also got amended by
Shri S.Eswara Reddy (Al) and Shri Animesh Kumar (A2) to favour
the company. It has further been stated through the charge sheet that
the investigation further revealed that Dinesh Dua (A3) in connivance
with Ms. Guljit Sethi @ Guljit Chaudhri (A4) and Shri L. Praveen
Kumar (A3), delivered Rs.04 Lakh as undue advantage to Shri
S.Eswara Reddy (Al) for favouring the company M/s BBL in the
matter of Insulin Aspart.
32. The CBI further submits thus, that the accused Shri S.Eswara
Reddy (A1), Shri Animesh Kumar (A2), Shri Dinesh Dua (A3), Ms.
Guljit Sethi (A4) & Shri L.Praveen Kumar (A5) entered into a
criminal conspiracy with each other, the purpose of which was to
favour M/s BBL in terms as mentioned above and in lieu of such
favour, the bribe was to be given to accused Shri S.Eswara Reddy
(A1) and in pursuance of the said criminal conspiracy, the accused
Shri S. Eswara Reddy (A1) in connivance with other co-accused
persons, favored M/s BBL and accordingly Shri S.Eswara Reddy (A1)
accepted the bribe amount of Rs.04 Lacs from Shri Dinesh Dua (A3)
at his residence on 20.06.2022 and during the transaction, the accused
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 20 of 35
Shri S.Eswara Reddy (A1) & Shri Dinesh Dua (A3) were apprehended
and the amount of Rs. 04 Lakhs was recovered and that further, a sum
of Rs.01 Lakh was also recovered from the physical possession of Shri
Dinesh Dua (A3) (which was also part of bribe amount of Rs. 05
Lakh) and as such all the said accused persons committed the offence.
33. It has been stated through the charge sheet that the accused
persons had committed the offences punishable u/s 120-B IPC r/w
Section 7, 7A & 8 of the PC Act, 1988 (as amended in 2018) on the
part of Sh. S. Eswara Reddy @ Sanapa Reddy (A1), Shri Animesh
Kumar (A2), Shri Dinesh Dua (A3), Ms. Guljit Sethi @ Guljit
Chaudhri (A4) & Sh. L. Praveen Kumar @ Praveen Kumar
Lakshminarayana (A5) and further constituted the substantive offence
punishable under Section 7 of PC Act 1988 (as amended in 2018) on
the part of Sh. S. Eswara Reddy @ Sanapa Reddy (A1), under Section
7A of PC Act 1988 (as amended in 2018) on the part of Shri Dinesh
Dua (A3) and under Section 8 of PC Act 1988 (as amended in 2018)
on the part of Ms. Guljit Sethi @ Guljit Chaudhri (A4) & Sh. L.
Praveen Kumar @ Praveen Kumar Lakshminarayana (A5) and that the
sanction order qua the accused Sh. S. Eswara Reddy @ Sanapa Reddy
(A1), Joint Drug Controller, CDSCO (HQ), New Delhi and Shri
Animesh Kumar (A2), Assistant Drug Inspector, CDSCO (HQ) are
awaited from the concerned department and that the further
investigation with respect to other allegations as alleged in the FIR
and the favour done to M/s BBL in respect of other drugs, analysis of
digital evidences, obtaining expert opinion from CFSL regarding
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 21 of 35
voice sample analysis and also on certain other aspects that cropped
up during investigation in the case, is still continuing.
34. The CBI has also submitted on record the rough transcript of
calls between L. Praveen Kumar (the applicant of Bail Appln. No.
2202/2022) and Guljit Sethito contend to the effect that L. Praveen
Kumar, Guljit Sethi, Animesh Kumar and Dinesh Dua, were all
involved in conspiring to put forth the amount of Rs.9 lakhs as bribe
money to Dr.S.Eswara Reddy to enable him to change the word
“ Data ” to “ Protocol ” so that the launch of the product “Insulin
Aspart” in India was made without the Phase-III clinical trial in the
country. During the stage when the application were being heard
the fulcrum of opposition on behalf of the CBI was that the
applicant could influence the investigation and tamper with the
evidence being in influential positions. As has been observed
elsewhere herein above, the charge sheet in relation to RC No.
RC0032022A0037 has already been filed .
35. Though undoubtedly during the course of submissions made on
behalf of the accused L.Praveen Kumar, the applicant of Bail Appln.
No 2202/2022, reliance was sought to be placed on the verdict of the
Hon‟ble Supreme Court in Satender Kumar Antil V. CBI : 2022 SCC
OnLine SC 825 and Arnesh Kumar v. State of Bihar & Anr. (2014) 8
SCC 273, it is essential to observe that as rightly contended by the
CBI that in this instant case, the CBI prima facie had information and
suspicion of commission of cognizable offences by the applicants as a
consequence of which issuance of the notice under Section 41A of the
Cr.P.C., 1973, was not required and all that was required was the
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 22 of 35
recording of reasons whilst making arrest of the applicants in terms of
Section 41(1)(b) thereafter which reads to the effect:
“41. When police may arrest without warrant.—
1. Any police officer may without an order from a
Magistrate and without a warrant, arrest any
person-
(a) …….
(b) against whom a reasonable complaint has
been made, or credible information has been
received, or a reasonable suspicion exists that he
has committed a cognizable offence punishable
with imprisonment for a term which may be less
than seven years or which may extend to seven
years whether with or without fine, if the following
conditions are satisfied, namely:—
(i) the police officer has reason to believe on the
basis of such complaint, information, or suspicion
that such person has committed the said offence;
(ii) the police officer is satisfied that such arrest is
necessary—
(a) to prevent such person from committing any
further offence; or
(b) for proper investigation of the offence; or
(c) to prevent such person from causing the
evidence of the offence to disappear or tampering
with such evidence in any manner; or
(d) to prevent such person from making any
inducement, threat or promise to any person
acquainted with the facts of the case so as to
dissuade him from disclosing such facts to the
Court or to the police officer; or
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 23 of 35
(e) as unless such person is arrested, his presence
in the Court whenever required cannot be ensured,
and the police officer shall record while making
such arrest, his reasons in writing:
Provided that a police officer shall, in all cases
where the arrest of a person is not required under
the provisions of this sub-section, record the
reasons in writing for not making the arrest.”
Thus, the arrest of the applicants in the instant case cannot be faulted
with.
36. Reliance was placed on behalf of the applicant Dinesh Dua, the
applicant of Bail Appln. No. 2290/2022, inter alia on the verdict of the
Hon‟ble Supreme Court in Sushila Aggarwal V. the State of NCT ;
(2020) 5 SCC 1which relates to the aspect of anticipatory bail and is
de hors the issue involved in the present bail application. Reliance
was also placed on behalf of the applicant Dinesh Dua on the verdict
of the Co-ordinate Bench of this Court in CBI V. Devendra Jain ;
2022 SCC OnLine Delhi 588 on observations in paragraphs 26, 27
and 29 thereof which read to the effect:-
“26. It was contended on behalf of the petitioner
that the accused/Akil Ahmad was habitual of
demanding bribe from contractors and so, there is
a larger conspiracy involved which needs to be
unearthed. But till date, no other material besides
what is already part of case records has been
placed on record to substantiate the allegation.
27. Notably, one of the grounds of challenge of the
impugned order is that sustained custodial
interrogation of the respondent is required, so he
may be confronted with co-accused persons,
including Uma Soni. However, this Court is of the
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 24 of 35
opinion that in view of the role assigned to the
respondent and in the absence of any other
material to substantiate the allegations levelled,
the ground raised is without any merit.
28. ……..
29. Keeping in view the foregoing, this Court is of
the view that the order granting bail does not
suffer from any kind of perversity. No ground is
made out to cancel the bail granted to the
respondent. However, to ensure the respondent's
availability during the trial, it is directed that in
addition to the bail conditions imposed by the
Court below, the respondent shall also surrender
his Passport with the concerned Investigating
Officer/CBI official within a period of 01 week
from the date of this judgment.”
to contend to the effect that where no material has been collected by
the Investigating Agency to unearth the alleged larger conspiracy
involved in the matter, the same is no ground to negate the grant of
bail to the applicant.
37. Reliance was also placed on behalf of the applicant Dinesh Dua
on the verdict of the Hon‟ble Supreme Court in Satender Kumar Antil
V. CBI ; 2022 OnLine SCC 825 on the observations in paragraphs 66
and 67 thereof which read to the effect:-
“66. What is left for us now to discuss are the
economic offences. The question for consideration
is whether it should be treated as a class of its own
or otherwise. This issue has already been dealt
with by this Court in the case of P. Chidambaram
v. Directorate of Enforcement, (2020) 13 SCC 791,
after taking note of the earlier decisions governing
the field. The gravity of the offence, the object of
the Special Act, and the attending circumstances
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 25 of 35
are a few of the factors to be taken note of, along
with the period of sentence. After all, an economic
offence cannot be classified as such, as it may
involve various activities and may differ from one
case to another. Therefore, it is not advisable on
the part of the court to categorise all the offences
into one group and deny bail on that basis. Suffice
it to state that law, as laid down in the following
judgments, will govern the field:—
Precedents
• P. Chidambaram v. Directorate of Enforcement,
(2020) 13 SCC 791: 23. Thus, from cumulative
perusal of the judgments cited on either side
including the one rendered by the Constitution
Bench of this Court, it could be deduced that the
basic jurisprudence relating to bail remains the
same inasmuch as the grant of bail is the rule and
refusal is the exception so as to ensure that the
accused has the opportunity of securing fair trial.
However, while considering the same the gravity
of the offence is an aspect which is required to be
kept in view by the Court. The gravity for the said
purpose will have to be gathered from the facts
and circumstances arising in each case. Keeping
in view the consequences that would befall on the
society in cases of financial irregularities, it has
been held that even economic offences would fall
under the category of “grave offence” and in such
circumstance while considering the application for
bail in such matters, the Court will have to deal
with the same, being sensitive to the nature of
allegation made against the accused. One of the
circumstances to consider the gravity of the
offence is also the term of sentence that is
prescribed for the offence the accused is alleged
to have committed. Such consideration with
regard to the gravity of offence is a factor which
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 26 of 35
is in addition to the triple test or the tripod test
that would be normally applied. In that regard
what is also to be kept in perspective is that even
if the allegation is one of grave economic offence,
it is not a rule that bail should be denied in every
case since there is no such bar created in the
relevant enactment passed by the legislature nor
does the bail jurisprudence provide so. Therefore,
the underlining conclusion is that respective of
the nature and gravity of charge, the precedent of
another case alone will not be the basis for either
grant or refusal of bail though it may have a
bearing on principle. But ultimately the
consideration will have to be on case-to case basis
on the facts involved therein and securing the
presence of the accused to stand trial .
(emphasis supplied)
• Sanjay Chandra v. CBI, (2012) 1 SCC 40:
“39. Coming back to the facts of the present case,
both the courts have refused the request for grant
of bail on two grounds : the primary ground is that
the offence alleged against the accused persons is
very serious involving deeprooted planning in
which, huge financial loss is caused to the State
exchequer; the secondary ground is that of the
possibility of the accused persons tampering with
the witnesses. In the present case, the charge is
that of cheating and dishonestly inducing delivery
of property and forgery for the purpose of cheating
using as genuine a forged document. The
punishment for the offence is imprisonment for a
term which may extend to seven years. It is, no
doubt, true that the nature of the charge may be
relevant, but at the same time, the punishment to
which the party may be liable, if convicted, also
bears upon the issue. Therefore, in determining
whether to grant bail, both the seriousness of the
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 27 of 35
charge and the severity of the punishment should
be taken into consideration.
40. The grant or refusal to grant bail lies within
the discretion of the court. The grant or denial is
regulated, to a large extent, by the facts and
circumstances of each particular case. But at the
same time, right to bail is not to be denied merely
because of the sentiments of the community against
the accused. The primary purposes of bail in a
criminal case are to relieve the accused of
imprisonment, to relieve the State of the burden of
keeping him, pending the trial, and at the same
time, to keep the accused constructively in the
custody of the court, whether before or after
conviction, to assure that he will submit to the
jurisdiction of the court and be in attendance
thereon whenever his presence is required.
xxx xxx xxx
46 . We are conscious of the fact that the accused
are charged with economic offences of huge
magnitude. We are also conscious of the fact that
the offences alleged, if proved, may jeopardise the
economy of the country. At the same time, we
cannot lose sight of the fact that the investigating
agency has already completed investigation and
the charge-sheet is already filed before the
Special Judge, CBI, New Delhi. Therefore, their
presence in the custody may not be necessary for
further investigation. We are of the view that the
appellants are entitled to the grant of bail
pending trial on stringent conditions in order to
ally the apprehension expressed by CBI. ”
(emphasis supplied)
ROLE OF THE COURT
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 28 of 35
67. The rate of conviction in criminal cases in
India is abysmally low. It appears to us that this
factor weighs on the mind of the Court while
deciding the bail applications in a negative sense.
Courts tend to think that the possibility of a
conviction being nearer to rarity, bail applications
will have to be decided strictly, contrary to legal
principles. We cannot mix up consideration of a
bail application, which is not punitive in nature
with that of a possible adjudication by way of trial.
On the contrary, an ultimate acq uittal with
continued custody would be a case of grave
injustice.”
to contend to the effect that economic offences cannot be classified as
a category of one group to deny bail on that basis to further submit to
the effect that in view of the factum that the Investigating Agency has
completed the investigation and the charge sheet has been filed, the
continued incarceration of the applicants in custody is no longer
required and they be released on bail pending trial on stringent
conditions in order to ally the apprehension expressed by the CBI.
Reliance was also placed on behalf of the applicant Dinesh Dua on the
verdict of the Hon‟ble Supreme Court in “State (NCT of Delhi v
Navjot Sandhu @ Afsan Guru” (2005) 11 SCC 600 to canvas the
extent of culpability for a conspiracy and to submit that there is
nothing to indicate that the applicant Dinesh Dua was in any manner
culpable of commission of any conspiracy with the other co-accused.
38. During the course of submissions that were put forth on behalf
of the CBI it has also been brought forth that the voice samples of the
accused persons have also been taken.
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 29 of 35
39. On a consideration of the entire available record taking into
account the factum that the charge sheet in the matter has been filed
and the investigation in the matter has also been completed and voice
samples of the accused persons have been taken, though undoubtedly
the offence alleged to have been committed (if proved) by the
applicants is grave, the trial in the matter would take ample time.
40. The applicants through the record appear to have roots in
society. Further there is nothing to indicate that despite the
recommendation made by the Special Expert Committee for waiver
of Phase-III clinical trial in the country to M/s Biocon Biologics to
import and market Insulin Aspart Injection for the treatment of the
diabetic condition subject to the condition that the Phase-IV clinical
trial in India would be conducted which also includes a sub-set
population to generate pharmacokinetic/ pharmacodynamic (PK/PD)
and immunogenicity and to submit the protocol to CDSCO before
placing the drug in the market as per guidelines in the country that the
said recommendation of the SEC has so far been approved and
given effect to by the Drug Controller General of India of the
Central Drugs Standard Control Organization . The contention
raised by Dr.S.Eswara Reddy (applicant of Bail Appln. No.
2262/2022) that he is neither the part of the Subject Expert Committee
nor the final authority to approve the content of the minutes of the
meeting of the Subject Expert Committee and that the Subject Expert
Committee consists of various outside experts of the field from
various government medical colleges and hospitals which are
approved by the Ministry of Health & Family Welfare, Government of
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 30 of 35
India, and that the SEC after duly deliberating over the formulation
and data provided by the manufacturer independently decides whether
to grant the recommendation for the approval of the drug or not and
the proceedings of which meeting are then reduced to draft minutes
and sent to the Drugs Controller of India to the Licensing Authority
for in principle checking and thereafter sending it to the members of
the SEC for their approval of the minutes of the meeting, cannot be
overlooked. The submission of the said applicant that it is only after
the approval of the minutes of the SEC members that the minutes are
published on the CDSCO website by the concerned authority has also
to be taken into account for as has already been observed herein above
there is nothing on the record to indicate that the approval of the
recommendation of the SEC has been approved by the Drugs
Controller General of India.
41. Likewise, a similar contention is raised by the applicant
Dr.L.Praveen Kumar (applicant of Bail Appln. No.2202/2022) to the
effect that no decision has been taken by the SEC till date and a mere
recommendation was made pursuant to which multiple stages ought to
follow based upon which decisions taken in these stages only an
approval can be granted as thus at this stage to be taken into account
for consideration of the grant or non-grant of the bail to the applicants.
42. Furthermore, the contention of the applicant Dr.S.Eswara
Reddy (applicant of Bail Appln. No.2262/2022) that Rule 101 of the
New Drugs and Clinical Trial Rules, 2019, which reads to the effect:
“101. Name of countries for purpose of new drug
approval- The Central Licencing Authority, with the
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 31 of 35
approval of the Central Government, may specify, by an
order, the name of the countries, from time to time, for
considering waiver of local clinical trial for approval of
new drugs under Chapter X and for grant of permission
for conduct of clinical trial under Chapter V.”
have essentially to be considered and that the medicine in question
has already been launched by the BBL and had undergone Phase I
clinical trial in Germany and Phase III trial in USA and the drug had
been approved and granted marketing authorization by European
Medicine Agency (EMA) and Health Canada, after enquiring its
quality, safety and efficacy was only a case of a launch of an approved
drug and only protocol had to be provided and there was no question
of change of the word “ Data ” to “ Protocol ”, are aspects which merit
consideration.
43. Another aspect that cannot be overlooked is that the alleged
recovery in the instant case is not pursuant to any usual trap
proceedings and the consideration of credibility of circumstantial
evidence would have to be assessed.
44. Another aspect which cannot be overlooked is that the alleged
intercepted calls between the accused persons have to be weighed at
the altar of admissibility and legality of evidence. It can also not be
overlooked as laid down by the Co-ordinate Bench of this Court in
Jatinder Pal Singh V. Central Bureau of Investigation ; Crl.M.C.
3118/2012 a verdict dated 17.1.2022 , admissibility of such evidence
with mandatory requirements of compliance of Section 5 of the Indian
Telegraph Act, 1885, is essential for interception of messages for the
exercise of powers under Sub-Section (2) of Section 5 of the Indian
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 32 of 35
Telegraph Act,1885, in the event of the occurrence of any public
emergency/existence of public safety interest which are the sine qua
non. Though the public health would undoubtedly amount to an issue
in relation to the public emergency or the existence of a public safety
interest, there is nothing presently placed on record to indicate the
invocation of Section5(2) of the Indian Telegraph Act, 1885 by the
CBI.
45. Section 5(2) of the Indian Telegaph Act, 1885, is as under:
“ 5. Power of government to take possession of
licensed telegraphs and to order interception of
messages.-
(1) xxx
(2) On the occurrence of any public emergency, or
in the interest of the public safety, the Central
Government or a State Government or any officer
specially authorised in this behalf by the Central
Government or a State Government may, if
satisfied that it is necessary or expedient so to do
in the interests of the sovereignty and integrity of
India, the security of the State, friendly relations
with foreign states or public order or for
preventing incitement to the commission of an
offence, for reasons to be recorded in writing, by
order, direct that any message or class of
messages to or from any person or class of
persons, or relating to any particular subject,
brought for transmission by or transmitted or
received by any telegraph, shall not be
transmitted, or shall be intercepted or detained, or
shall be disclosed to the Government making the
order or an officer thereof mentioned in the order:
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 33 of 35
Provided that the press messages intended
to be published in India of correspondents
accredited to the Central Government or a State
Government shall not be intercepted or detained,
unless their transmission has been prohibited
under this sub-section.]
46. Furthermore, the offences alleged to have been committed by
the applicants are punishable with imprisonment to a maximum of
seven years of imprisonment.
47. The applicants, i.e., Dr. L. Praveen Kumar (applicant of Bail
Appln. No. 2202/2022), Dinesh Dua (applicant of Bail Appln. No.
2290/2022) and S. Eswara Reddy (applicant of Bail Appln. No.
2262/2022) apparently are not flight risks and are thus allowed to be
released on bail on their furnishing a personal bond in the sum of
Rs.1,00,000/- each with two sureties of the like amount to the
satisfaction of the Trial Court with directions:
the applicants shall surrender their passports before the Trial
Court at the time of submission of the bail bonds and surety
bonds;
the applicants shall under no circumstances leave the country,
the applicants shall appear before the Trial Court as and when
directed;
that the applicants shall keep their mobile phone on at all times
and drop a pin on the Google map to ensure that their location is
available to the Investigating Officer;
that the applicants shall commit no offence whatsoever during
the period that they are on bail in the instant case and;
that the applicants shall make no attempt to influence the
prosecution witnesses.
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 34 of 35
48. Nothing stated herein above shall however amount to any
expression on the merits or demerits of the trial that may take place.
49. The Bail Appln. No. 2202/2022 along with Crl.M.(Bail) No.
885/2022, Bail Appln. No.2290/2022 with CRL.M.(BAIL) 915/2022
and Bail Appln. No.2262/2022 are disposed of accordingly.
50. The date 08.09.2022 in CRL.M.(BAIL) 915/2022 is thus,
cancelled.
ANU MALHOTRA, J.
SEPTEMBER 06, 2022
Nc/sv
Signature
Not Verified
Digitally Signed
By:SUMIT GHAI
Signing
Date:06.09.2022
11:02:42
This file is
digitally signed by
PS to HMJ ANU
MALHOTRA.
Bail.Appl.No.2202/2022, 2290/2022 & 2262/2022 Page 35 of 35